|4May 17, 3:13 PM ET

Gitman Paul 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 17, 2019

Insider Transaction Report

Form 4
Period: 2019-05-15
Gitman Paul
Director
Transactions
  • Sale

    Common Stock, $0.001 par value

    2019-05-15$65.83/sh5,000$329,15015,000 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES